Rockwell Medical, Inc. (RMTI) stock
RMTINasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 11/3080% below fair value
$6.61−0.15 (-2.22%)
Close on Nov 17, 2026Market cap $26.64MP/E –Yield –
Rockwell Medical enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Rockwell Medical's enterprise value was $265.42M on Nov 11, 2026, against $24.26M a year earlier. Over the last 5 years it ranged from -$6.06M to $323.41M, with a median of $29.18M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $265.42M | +1384.4% |
| 2025 | Dec 31, 2025 | $17.88M | -68.1% |
| 2024 | Dec 31, 2024 | $56.01M | +9.6% |
| 2023 | Dec 29, 2023 | $51.11M | – |
| 2022 | Dec 30, 2022 | -$2.24M | -108.4% |
| 2021 | Dec 31, 2021 | $26.55M | -44.7% |
| 2020 | Dec 31, 2020 | $48.05M | -66.0% |
| 2019 | Dec 31, 2019 | $141.46M | +25.5% |
| 2018 | Dec 31, 2018 | $112.71M | -62.1% |
| 2017 | Dec 29, 2017 | $297.36M | -6.6% |
| 2016 | Dec 30, 2016 | $318.21M | -33.9% |
| 2015 | Dec 31, 2015 | $481.16M | +9.7% |
| 2014 | Dec 31, 2014 | $438.64M | +5.3% |
| 2013 | Dec 31, 2013 | $416.37M | +178.6% |
| 2012 | Dec 31, 2012 | $149.44M | +0.8% |
| 2011 | Dec 30, 2011 | $148.30M | – |
See a number that looks wrong?